Clinical Trial Update: A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients [Phase 1]

View source ↗

Summary

Phase I study of QLS12010 capsules evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects in healthy adults and patients with ato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Hidradenitis Suppurativa
• Rheumatoid Arthritis

Drugs mentioned

• QLS12010 Capsules

Snippet

Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD | Conditions: Atopic Dermatitis, Hidradenitis Suppurativa (HS) | Phase 1 | Status: RECRUITING